Aveanna Healthcare Holdings, Inc.(AVAH)— Stock Profile, AI Score & Financials
Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
Aveanna Healthcare Holdings, Inc. (AVAH) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores AVAH at 65.6/100 on a 32-signal composite quality model, placing it at rank #472 of 2,960 stocks — the top 25% of the AI-ranked universe. AVAH scores in the top quartile across balance sheet strength (91.9). Based on the latest XBRL financial filings (Q2 2026), Aveanna Healthcare Holdings, Inc. reports quarterly revenue of $670.5M, net income of $40.3M, an operating margin of 11.9%. Top institutional holders of AVAH by reported 13-F value include BAIN CAPITAL INVESTORS, J.H. Whitney Equity Partners VII, Nut Tree Capital Management, based on the most recent SEC filings. AVAH trades on the Nasdaq exchange and files with the SEC under CIK 1832332. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AVAH daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Aveanna Healthcare Holdings, Inc. directly from SEC EDGAR.
AI Quality Score
65.6/100
AI Rank
#472
Revenue
$670.5M
Net Income
$40.3M
Operating Margin
11.9%
AVAH key financials by period
Aveanna Healthcare Holdings, Inc. reported revenue, net income and margins by fiscal period, from SEC filings.
Period
Form
Revenue
Net income
Operating margin
FY 2025
10-K
$2.4B
$225.0M
10.5%
FY 2024
10-K
$2.0B
$-10.9M
6.9%
FY 2023
10-K
$1.9B
$-134.5M
0.4%
FY 2022
10-K
$1.8B
$-662.0M
-35.9%
FY 2021
10-K
$1.7B
$-117.0M
-2.1%
FY 2020
10-K
$1.5B
$-57.0M
-0.2%
Institutions holding AVAH
Institutional investors reporting a position in Aveanna Healthcare Holdings, Inc. on SEC Form 13F.
AI-extracted from the 10-Q filed 2026-08-13 — Q2 FY2026 (quarter ended July 4, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Biggest Revenue Drivers
Private Duty Services (PDS)$553.9M+14.0% YoY
12.3% volume growth in demand for non-clinical services and acquisitions, plus 1.7% revenue rate increase from Medicaid rate hikes and improved implicit price concessions.
Home Health & Hospice (HHH)$69.0M+14.8% YoY
18.5% increase in total episodes; home health episodic mix improved to 81.0% from 74.5% prior year.
Biggest Revenue Drivers
Total revenue: $670.5M+13.7% YoY
Private Duty Services (PDS)$553.9M+14.0% YoY
12.3% volume growth in demand for non-clinical services and acquisitions, plus 1.7% revenue rate increase from Medicaid rate hikes and improved implicit price concessions.
Home Health & Hospice (HHH)$69.0M+14.8% YoY
18.5% increase in total episodes; home health episodic mix improved to 81.0% from 74.5% prior year.
Medical Solutions (MS)$47.5M+9.4% YoY
4.4% volume growth and 5.0% revenue rate increase.
Largest Expense Items
Cost of revenue, excluding depreciation and amortization$452.0M+19.3% YoY
Higher caregiver labor costs including pass-through of reimbursement rate increases; higher general and professional liability reserves; Q2 2025 included $6.2M release of legal settlements not recurring.
Branch and regional administrative expenses$97.1M+7.8% YoY
Additional branch operations from Thrive and Family First acquisitions and costs to integrate acquired operations.
Interest expense, net of interest income$26.5M-26.1% YoY
Lower U.S. federal funds rate, May 2026 credit facility repricing reducing margins by 75bp, and refinancing benefit reduced weighted average rate from 9.0% to 6.6%.
Acquisition-related costs$4.4M+29.1% YoY
Costs associated with Family First acquisition completed June 1, 2026.
Watch Items from the Filing
PDS cost of revenue rate increased 7.8% YoY, outpacing 1.7% revenue rate growth, compressing spread rate 11.1%. Management attributes this to higher caregiver labor costs and liability reserves; sustained cost pressure could limit margin expansion.
Medicaid MCO represents 59.4% of total revenue. Management notes risks from changes to Medicaid under the One Big Beautiful Bill Act and downward pressure from Medicare Advantage plan proliferation.
Company completed $173.7M cash acquisition of Family First on June 1, 2026, funded from cash on hand. Goodwill of $156.2M recognized; integration costs ongoing. DSO stable at 45.5 days.
Outstanding variable rate debt of $1.5B as of July 4, 2026 with interest rate caps on $1.4B notional. Unhedged exposure of $83.4M would see interest expense increase $2.7M annually per 100bp rate rise.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
